Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02131805 · ClinicalTrials.gov registry record · NA
Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT02131805: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02131805 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02131805, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of electronic skin surface brachytherapy (ESSB) for early stage basal or squamous cell carcinoma of the skin using a new device. This new device is Nucletron's Esteya Electronic Skin Surface Brachytherapy System. The investigators want to understand what effects, good and/or bad this device for delivering brachytherapy has on your skin cancer. The investigators also want to assess the safety, cosmetic results, the effects that ESSB has on quality of life and to correlate skin imaging with clinical response to ESSB.
Interventions
- RADIATION Electronic Skin Surface Brachytherapy
- BEHAVIORAL Quality of life assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2014-05 |
| Est. Completion | 2025-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02131805
The ClinicalTrials.gov registry entry for NCT02131805 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electronic Skin Surface Brachytherapy is the first listed.
NCT02131805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02131805 about?
NCT02131805 is a clinical study titled "Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma". The purpose of this study is to assess the effectiveness of electronic skin surface brachytherapy (ESSB) for early stage basal or squamous cell carcinoma of the skin using a new device. This new device is Nucletron's Esteya Electronic Skin Surface Brachytherapy System. The investigators want to unde...
What is the current status of trial NCT02131805?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2014-05. Estimated completion is 2025-12-23.
What interventions are being tested in trial NCT02131805?
The interventions under investigation include: Electronic Skin Surface Brachytherapy (RADIATION), Quality of life assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02131805?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.